Economic Analysis In Off-Label Promotion Cases
In an increasing number of government investigations, the central allegation is that a pharmaceutical manufacturer promoted one of its products off-label. Many of these investigations have resulted in hundreds of millions...To view the full article, register now.
Already a subscriber? Click here to view full article